Evaluation and interference of serum and skin lesion levels of leukotrienes in patients with eczema

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 75, Issue 1, 2006, Pages 51-55

  Hua, Zhong ^a   Fei, Hao ^a   Mingming, Xiang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; LEUKOTRIENE; MIZOLASTINE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ECZEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SKIN; SKIN MANIFESTATION; TISSUE LEVEL; TREATMENT OUTCOME; URINE LEVEL;

ADOLESCENT; ADULT; BENZIMIDAZOLES; CASE-CONTROL STUDIES; ECZEMA; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE E4; LEUKOTRIENES; MALE; MIDDLE AGED; SKIN; TREATMENT OUTCOME;

EID: 33746056845     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2006.02.007     Document Type: Article

References (12)

1. Reilly D., Parslew R., Sharpe G., et al. Inflammatory mediators in normal, sensitive and diseased skin types. Acta Derm. Venereal 80 3 (2000) 171-174
2. Yuka S., Kazuhiko T., and Shinichi S. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J. Dermatol. Sci. 34 3 (2004) 201-208
3. Lowry O., Rosebrough N., Farr A., et al. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
4. Tofte S., Braeber M., Cherill R., et al. Eczema area and severity index(EASI): A new tool to evaluate atopic dermatitis. J. Eur. Acad. Dermatol. Venereol. 11 Suppl. 2 (1998) S197
5. Sofia B.P., Gennady Y.M., Galina R.P., et al. Dietary phospholipids in chronic eczema. Prostaglandins Other Lipid Mediat. 59 1-6 (1999) 207
6. Thestrup-Pedersen K. Cytokines and skin diseases. Nord. Med. 110 3 (1995) 79-81
7. Colin D.F. Prostagladins and leukotrienes: advances in eicosanoid biology. Science 294 30 (2001) 1871-1875
8. Bos J.D., Sillevi J.H., and Smitt S. Atopic dermatitis. J. Eur. Acad. Dermatol. Venereol. 7 2 (1996) 101-114
9. Kouichi I. Psoriasis and the arachidonic acid cascade. J. Dermatol. Sci. 21 3 (1999) 135-146
10. Nanette B.S., and Amy S.P. Leukotriene receptor antagonists are ineffective for severe atopic dermatitis. J. Am. Acad. Dermatol. 50 3 (2004) 485-486
11. Iftikhar H., Kunihiko K., Thomas R.B., et al. Expression of cysteinyl leukotriene receptor-1 in skin. J. Am. Acad. Dermatol. 51 6 (2004) 1032-1033
12. Triggiani M., Giannattasio G., Balestrieri B., et al. Differential modulation of mediator release from human basophils and mast cells by mizolastine. Clin. Exp. Allergy 34 2 (2004) 241-249